Glucocerebrosidase Mutations in Gaucher Disease

Publisher Website
Google Scholar
Abstract
Thirty-six mutations that cause Gaucher disease, the most common glycolipid storage disorder, are known. Although both alleles of most patients with the disease contain one of these mutations, in a few patients one or both disease-producing alleles have remained unidentified. Identification of mutations in these patients is useful for genetic counseling. The DNA from 23 Gaucher disease patients in whom at least one glucocerebrosidase allele did not contain any of the 36 previously described mutations has been examined by single strand conformation polymorphism (SSCP) analysis, followed by sequencing of regions in which abnormalities were detected. Eight previously undescribed mutations were detected. In exon 3, a deletion of a cytosine at cDNA nt 203 was found. In exon 6, three missense mutations were identified: a C→A transversion at cDNA nt 644 (Ala176→Asp), a C→A transversion at cDNA nt 661 that resulted in a (Pro182→Thr), and a G→A transition at cDNA nt 721(Gly202→Arg). Two missense mutations were found in exon 7: a G→A transition at cDNA nt 887 (Arg257→Gln) and a C→T at cDNA nt 970 (Arg285→Cys). Two missense mutations were found in exon 9: a T→G at cDNA nt 1249 (Trp378→Gly) and a G→A at cDNA nt 1255 (Asp380→Asn). In addition to these disease-producing mutations, a silent C→G transversion at cDNA nt 1431, occurring in a gene that already contained the 1226G mutation, was found in one family. The mutations described here and previously known can be classified as mild, severe, or lethal, on the basis of their effect on enzyme production and on clinical phenotype, and as polymorphic or sporadic, on the basis of the haplotype in which they are found. Rare mutations such as the new ones described here are sporadic in nature.